Literature DB >> 23890067

PTPN22 in autoimmunity: different cell and different way.

Lionel B Ivashkiv1.   

Abstract

The tyrosine phosphatase PTPN22 regulates T cell receptor signaling. In this issue of Immunity, Wang et al. (2013) show that in myeloid cells PTPN22 potentiates TLR-induced type I interferon production and that autoimmunity-associated allele PTPN22W encodes a reduced-function variant.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23890067      PMCID： PMC3785409          DOI： 10.1016/j.immuni.2013.07.007

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  10 in total

1.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

Authors:  Garth L Burn; Lena Svensson; Cristina Sanchez-Blanco; Manoj Saini; Andrew P Cope
Journal:  FEBS Lett       Date:  2011-04-20       Impact factor: 4.124

3.  The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment.

Authors:  Rachael A Gordon; Galina Grigoriev; Angela Lee; George D Kalliolias; Lionel B Ivashkiv
Journal:  Arthritis Rheum       Date:  2012-10

4.  Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs.

Authors:  Anna Yarilina; Edward DiCarlo; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 5.  Expanding TRAF function: TRAF3 as a tri-faced immune regulator.

Authors:  Hans Häcker; Ping-Hui Tseng; Michael Karin
Journal:  Nat Rev Immunol       Date:  2011-06-10       Impact factor: 53.106

6.  Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

Authors:  Kyoko Katakura; Jongdae Lee; Daniel Rachmilewitz; Gloria Li; Lars Eckmann; Eyal Raz
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

7.  Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.

Authors:  J Zheng; S Ibrahim; F Petersen; X Yu
Journal:  Genes Immun       Date:  2012-10-18       Impact factor: 2.676

8.  The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.

Authors:  Yaya Wang; Iftach Shaked; Stephanie M Stanford; Wenbo Zhou; Julie M Curtsinger; Zbigniew Mikulski; Zachary R Shaheen; Genhong Cheng; Kristy Sawatzke; Amanda M Campbell; Jennifer L Auger; Hatice Bilgic; Fernanda M Shoyama; David O Schmeling; Henry H Balfour; Kiminori Hasegawa; Andrew C Chan; John A Corbett; Bryce A Binstadt; Matthew F Mescher; Klaus Ley; Nunzio Bottini; Erik J Peterson
Journal:  Immunity       Date:  2013-07-18       Impact factor: 31.745

9.  Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.

Authors:  Marco Prinz; Hauke Schmidt; Alexander Mildner; Klaus-Peter Knobeloch; Uwe-Karsten Hanisch; Jenni Raasch; Doron Merkler; Claudia Detje; Ilona Gutcher; Jörg Mages; Roland Lang; Roland Martin; Ralf Gold; Burkhard Becher; Wolfgang Brück; Ulrich Kalinke
Journal:  Immunity       Date:  2008-05       Impact factor: 31.745

10.  Overview of the biology of type I interferons.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156
  10 in total
  8 in total

1.  RNASET2, GPR174, and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves' disease.

Authors:  Qing Zhang; Shaozheng Liu; Yanxing Guan; Qingjie Chen; Qing Zhang; Xiang Min
Journal:  J Clin Lab Anal       Date:  2017-05-31       Impact factor: 2.352

Review 2.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

3.  The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.

Authors:  J F Mendoza Rincón; D López Cano; S Jiménez Morales; M L Rivas Jiménez; R E Barbosa Cobos; J Ramírez Bello
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

Review 4.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

Review 5.  Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art.

Authors:  Francesco Bonatti; Michele Reina; Tauro Maria Neri; Davide Martorana
Journal:  Front Immunol       Date:  2014-11-17       Impact factor: 7.561

6.  An IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets.

Authors:  Erna Domsgen; Katharina Lind; Lingjia Kong; Michael H Hühn; Omid Rasool; Frank van Kuppeveld; Olle Korsgren; Riitta Lahesmaa; Malin Flodström-Tullberg
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

Review 7.  Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.

Authors:  Ivan Hirsch; Vaclav Janovec; Ruzena Stranska; Nathalie Bendriss-Vermare
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

8.  Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp620 Risk Allele Drive the Expansion of FOXP3+ Regulatory T Cells and PD-1 Expression.

Authors:  Ricardo C Ferreira; Xaquin Castro Dopico; João J Oliveira; Daniel B Rainbow; Jennie H Yang; Dominik Trzupek; Sarah A Todd; Mhairi McNeill; Maristella Steri; Valeria Orrù; Edoardo Fiorillo; Daniel J M Crouch; Marcin L Pekalski; Francesco Cucca; Tim I Tree; Tim J Vyse; Linda S Wicker; John A Todd
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.